Conclusions on three active substances and four applications for Union authorisation
The Biocidal Products Committee (BPC) adopted three opinions on active substances, including one proposing non-approval, and four opinions on Union authorisation – with one not supporting authorisation.
Helsinki, 9 March 2020 – The BPC concluded on the applications for the following active substance product-type combinations:
- Chlorophene for product-type 2 (disinfectants and algaecides not intended for direct application to humans or animals);
- Glyoxal for product-types 2, 3 (veterinary hygiene) and 4 (food and feed area);
- Reaction mass of peracetic acid and peroxyoctanoic acid for product-types 2, 3 and 4.
The committee’s opinion is that chlorophene cannot be approved as a heavy-duty disinfectant as there are unacceptable risks that cannot be mitigated. According to the committee’s opinion the two other active substances can be approved.
The BPC also adopted opinions on four applications for Union authorisation of a biocidal product family based on the following active substances:
- propan-2-ol in product-types 2 and 4;
- CMIT/MIT in product-type 6 (preservatives for products during storage);
- peracetic acid in product-type 2; and
- hydrogen peroxide in product-type 2.
The committee’s opinion is that the biocidal product family based on hydrogen peroxide cannot be authorised as it cannot be demonstrated that this product family is sufficiently effective to act as a disinfectant.
The European Commission together with the EU Member States will take the final decision on the approval of the active substances and on the Union authorisation of the biocidal product families.
The committee met from 4 to 5 March 2020. The opinions will be available on ECHA’s website in the near future. The next meeting will be in June 2020.